288154-16-5

Usage

Chemical Properties

White powder

InChI:InChI=1/C19H26N2O6/c1-18(2,3)27-17(25)21-11-9-19(10-12-21,15(22)23)20-16(24)26-13-14-7-5-4-6-8-14/h4-8H,9-13H2,1-3H3,(H,20,24)(H,22,23)

Upstream product

• 41979-39-9 4-piperidone hydrochloride 
• 501-53-1 benzyl chloroformate 
• 183673-68-9 1-tert-butyloxycarbonylpiperidine-4-spiro-5'-(1',3'-bis(tertbutyloxy-carbonyl))hydantoin 
• 183673-70-3 tert-butyl 2,4-dioxo-1,3,8-triazaspiro[4.5]decane-8-carboxylate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 183673-71-4 4-amino-1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid 
• 321997-89-1 methyl 1-tert-butyloxycarbonyl-4-aminopiperidin-4-carboxylate 
• 13625-39-3 1,3,8-triaza-spiro[4.5]decan-2,4-dione 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 940290-02-8 4-[(benzyloxycarbonyl)amino]-1-(tert-butyloxycarbonyl)piperidine-4-carboxylic acid tryptamide 
• 392331-67-8 1-(tert-butyl) 4-methyl 4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)piperidine-1,4-dicarboxylate 
• 917834-41-4 tert-butyl 4-(benzyloxycarbonylamino)-4-(hydroxymethyl)piperidine-1-carboxylate 
• 1091681-76-3 4-benzyloxycarbonylamino-4-chloromethyl-piperidine-1-carboxylic acid tert-butyl ester 
• 1091681-78-5 4-benzyloxycarbonylamino-4-(4-fluoro-benzyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 1091681-82-1 [1-((S)-2-tert-butoxycarbonylamino-3,3-dimethyl-butyryl)-4-(4-fluoro-benzyl)-piperidin-4-yl]-carbamic acid benzyl ester 
• 1091681-80-9 [4-(4-fluoro-benzyl)-piperidin-4-yl]-carbamic acid benzyl ester hydrochloride 
• 1091682-14-2 (R)-N-{(S)-1-[4-amino-4-(4-fluoro-benzyl)-piperidine-1-carbonyl]-2,2-dimethyl-propyl}-2-cyclopentylmethyl-3-(formyl-hydroxy-amino)-propionamide 
• 1091681-74-1 [1-((S)-2-amino-3,3-dimethyl-butyryl)-4-(4-fluoro-benzyl)-piperidin-4-yl]-carbamic acid benzyl ester hydrochloride 
• 1091682-16-4 {1-{(S)-2-[(R)-3-(benzyloxyl-formyl-amino)-2-cyclopentylmethyl-propionylamino]-3,3-dimethy-butyryl}-4-(4-fluoro-benzyl)-piperidin-4-yl}-carbamic acid benzyl ester 

Relevant academic research and scientific papers

Discovery of SHR0687, a Highly Potent and Peripheral Nervous System-Restricted KOR Agonist

Analgesics with no abuse liability are highly demanded in the market. KOR agonists have been proved to be strong analgesics without MOR agonist-related side effects, such as respiratory depression, tolerance, and dependence liability; however, activation

A NEW PEPTIDE DEFORMYLASE INHIBITOR COMPOUND AND MANUFACTURING PROCESS THEREOF

The present invention relates to the novel antibacterial compounds having potent antibacterial activity as inhibitors of peptide deformylase. This invention further relates to pharmaceutically acceptable salts thereof, to processes for their preparation, and to pharmaceutical compositions containing them as an active ingredient.

A NEW PEPTIDE DEFORMYLASE INHIBITOR COMPOUND AND MANUFACTURING PROCESS THEREOF

The present invention relates to the novel antibacterial compounds having potent antibacterial activity as inhibitors of peptide deformylase. This invention further relates to pharmaceutically acceptable salts thereof, to processes for their preparation, and to pharmaceutical compositions containing them as an active ingredient.

N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors

A series of N-(3-(4-hydroxyphenyl)-propenoyl)-amino acid tryptamides was based on a previously reported new SIRT2 inhibitor from our group, and it was designed to study if the molecular size of the compound could be reduced. The most potent compounds, N-(3-(4-hydroxyphenyl)-propenoyl)-2-aminoisobutyric acid tryptamide and N-(3-(4-hydroxyphenyl)-propenoyl)-l-alanine tryptamide, were equipotent, 30% smaller in molecular weight, and slightly more selective (SIRT2/SIRT1) than the parent compound.

MELANOCORTIN RECEPTOR AGONISTS

The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.

Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity

Aminopiperidine derivatives of formula (I) and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly in man.

Quinoline derivatives as antibacterials

Aminopiperidine derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly in man.